| Patents for C07D 215 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems (27,676) |
|---|
| 05/02/2013 | US20130109717 Solid forms of n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide |
| 05/02/2013 | US20130109713 Antimicrobial agents |
| 05/02/2013 | US20130109672 Activators of human pyruvate kinase |
| 05/02/2013 | US20130108605 Method of ameliorating oxidative stress and supplementing the diet |
| 05/02/2013 | CA2853366A1 Quinolines as fgfr kinase modulators |
| 05/01/2013 | EP2584916A1 Organic compounds |
| 05/01/2013 | CN103080092A Pyrazolo-quinolines |
| 05/01/2013 | CN103073499A Method for preparing rhenium ion liquid by extraction method |
| 05/01/2013 | CN103073493A Triazene compound, preparation method, and method for determination of cadmium content |
| 05/01/2013 | CN103073492A Synthesis method of 2-(3-(S)-(3-(2-7-chlorine-2-quinolyl) vinyl) phenyl)-3-hydroxypropyl) benzoate |
| 05/01/2013 | CN103073491A Synthetic method of 2-(5,7-difluoro-6-quinolyl) acetic acid/propionic acid (ester) |
| 05/01/2013 | CN103073460A Arylsulfonylmethyl or arylsulfonamide substituted aromatic compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor |
| 05/01/2013 | CN102017218B Organic electroluminescent element |
| 05/01/2013 | CN101962359B Hapten, artifical antigen and antibody of enrofloxacin and preparation method as well as application thereof |
| 05/01/2013 | CN101723935B 1,5-diaryl-substituted 2,4-dienone derivative as well as preparation method and application thereof |
| 05/01/2013 | CN101679270B Dihydroquinone and dihydronaphthridine inhibitors of JNK |
| 05/01/2013 | CN101514188B Method for preparing 8-hydroxyquinoline metal compounds |
| 04/30/2013 | US8431706 1,2,3,4-tetrahydroqinoline derivative useful for the treatment of diabetes |
| 04/30/2013 | US8431704 Quinoline or isoquinoline substituted P2X7 antagonists |
| 04/30/2013 | US8431574 Heterocyclic inhibitors of MEK and methods of use thereof |
| 04/25/2013 | WO2013059788A1 Process for preparing quinoline derivatives |
| 04/25/2013 | WO2013058511A2 Method for preparing high-purity montelukast sodium salt |
| 04/25/2013 | WO2013057320A1 (hetero)aryl cyclopropylamine compounds as lsd1 inhibitors |
| 04/25/2013 | US20130102756 Novel curing agents |
| 04/25/2013 | US20130102632 Substituted heterocyclic compounds as ion channel modulators |
| 04/25/2013 | US20130102631 Novel microbiocidal dioxime ether derivatives |
| 04/25/2013 | US20130102609 Biaryl oxyacetic acid compounds |
| 04/25/2013 | US20130101684 Compounds, Compositions, And Methods For Reducing Or Eliminating Bitter Taste |
| 04/25/2013 | US20130098770 Plating bath and method |
| 04/25/2013 | CA2852771A1 Process for preparing quinoline derivatives |
| 04/25/2013 | CA2852355A1 (hetero)aryl cyclopropylamine compounds as lsd1 inhibitors |
| 04/24/2013 | EP2582676A1 Tetrahydroquinoline amide m1 receptor positive allosteric modulators |
| 04/24/2013 | EP2582672A1 X-ray and gamma-photon activable organic compounds, their preparation and their uses |
| 04/24/2013 | EP2582667A1 Heterocyclic substituted methoxyphenyl derivatives having an oxo group, method for producing same, and use thereof as gpr40 receptor modulators |
| 04/24/2013 | CN103068804A Substituted 2-oxy-quinoline-3-carboxamides as kcnq2/3 modulators |
| 04/24/2013 | CN103068803A Imidazo[4,5-c]quinolines as DNA-PK inhibitors |
| 04/24/2013 | CN103059837A Method for preparing two 4-[(8-hydroxy-5-quinolinyl)azo] cadmium benzenesulfonate complexes with blue light performance |
| 04/24/2013 | CN103059836A Method for preparing 4-[(8-hydroxy-5-quinolinyl)azo] cadmium benzoate complex with purple light performance |
| 04/24/2013 | CN103058957A NMDA receptor antagonists for neuroprotection |
| 04/24/2013 | CN103058927A Quinoline and application thereof |
| 04/24/2013 | CN103058926A Preparation method of 7-chlorine-4-(piperazineyl-1-yl) quinoline |
| 04/24/2013 | CN103058925A Method for preparing pitavastatin calcium |
| 04/24/2013 | CN103058924A Method for extracting high-purity 8-methylquinoline |
| 04/24/2013 | CN103058923A Method for extracting high-purity 6-methylquinoline |
| 04/24/2013 | CN102229561B Method for preparing 2, 2-disubstituted 1, 2-dihydro quinoline derivative |
| 04/24/2013 | CN101583280B Novel hydrophilic derivatives of 2-aryl-4-quinolones as anticancer agents |
| 04/23/2013 | US8426600 Method for preparing montelukast sodium salts |
| 04/23/2013 | US8426599 Method for preparation of Montelukast acid in ionic liquid medium |
| 04/23/2013 | US8426598 N-heterocyclic M1 receptor positive allosteric modulators |
| 04/23/2013 | US8426597 Nitrate derivatives of cilostazol for the treatment of vascular and metabolic diseases |
| 04/23/2013 | US8426586 Using a acyl bromine compound; activation with phosphonacetic acid |
| 04/23/2013 | US8426431 Substituted 2-aminoacetamides and the use thereof |
| 04/23/2013 | CA2634168C Quinolone based compounds exhibiting prolyl hydroxylase inhibitory activity, and compositions, and uses thereof |
| 04/18/2013 | US20130096303 Process for the preparation of hmg-coa reductase inhibitors and intermediates thereof |
| 04/18/2013 | US20130096159 Inhibitors of human 12-lipoxygenase |
| 04/18/2013 | US20130096157 Quinoline derivatives and uses of the same |
| 04/18/2013 | US20130096156 Quinoline derivatives as fungicides |
| 04/18/2013 | US20130096138 Novel thiourea or urea derivative, preparation method thereof, and pharmaceutical composition for preventing or treating aids, containing same as active ingredient |
| 04/18/2013 | US20130096122 Fused heterocyclic compounds as ion channel modulators |
| 04/17/2013 | EP2580199A1 Quinoline derivatives as fungicides |
| 04/17/2013 | CN103044263A Preparing method for medicament midbody for treating cystic fibrosis |
| 04/17/2013 | CN102164897B Method for preparing montelukast sodium salts |
| 04/16/2013 | US8420821 Process for production of 4-oxoquinoline compound |
| 04/16/2013 | US8420812 Process for the palladium-catalyzed coupling of terminal alkynes with heteroaryl tosylates and heteroaryl benzenesulfonates |
| 04/16/2013 | US8420670 4-benzylaminoquinolines, pharmaceutical compositions containing them, and their use in therapy |
| 04/16/2013 | US8420665 Anti-cancer compounds |
| 04/16/2013 | US8420661 Arylethynyl derivatives |
| 04/16/2013 | CA2566388C Enantioselective preparation of quinoline derivative |
| 04/16/2013 | CA2548273C Substituted 6-cyclohexylalkyl substituted 2-quinolinones and 2-quinoxalinones as poly(adp-ribose) polymerase inhibitors |
| 04/11/2013 | WO2013051901A2 Novel adamantane derivative compound 신규 아다만탄 유도체 화합물 |
| 04/11/2013 | WO2013051024A2 Cysteinyl leukotriene antagonists |
| 04/11/2013 | WO2013050721A1 Compounds that trap alpha-oxoaldehydes and alpha-beta-unsaturated aldehydes, meta-compounds containing such compounds, and use of said compounds in treating illnesses related to the accumulation of ages and ales |
| 04/11/2013 | WO2013050375A1 Process for preparing 5-(2-{[6-(2,2-difluoro-2-phenylethoxy)hexyl]amino}-1(r)-hydroxyethyl)-8-hydroxyquinolin-2(1h)-one via a novel intermediate |
| 04/11/2013 | WO2012167237A3 Compounds having antiparasitic or anti-infectious activity |
| 04/11/2013 | CA2846444A1 Process for preparing 5-(2-{[6-(2,2-difluoro-2-phenylethoxy)hexyl]amino}-1(r)-hydroxyethyl)-8-hydroxyquinolin-2(1h)-one via a novel intermediate |
| 04/11/2013 | CA2842881A1 Cysteinyl leukotriene antagonists |
| 04/10/2013 | EP2578570A1 Novel process for preparing 5-(2-{[6-(2,2-difluoro-2-phenylethoxy)hexyl]amino}-1(r)-hydroxyethyl)-8-hydroxyquinolin-2(1h)-one via novel intermediates of synthesis. |
| 04/10/2013 | CN103038217A Novel microbiocidal dioxime ether derivatives |
| 04/10/2013 | CN103030658A Industrial production method of diisopinocampheyl chloroborane |
| 04/10/2013 | CN101058558B 4-Oxy-1(4H)-quinoline carboxylic acids compound and composition with aldose reductase inhibition activity and preparation method thereof |
| 04/09/2013 | US8415475 Antibacterial quinoline derivatives |
| 04/09/2013 | US8415272 Quinoline derivatives and their use as fungicides |
| 04/09/2013 | CA2659590C Irreversible protein tyrosine kinases inhibitors and the preparation methods and uses thereof |
| 04/09/2013 | CA2587642C Substituted heterocycles and methods of use |
| 04/04/2013 | WO2013048942A1 Quinolinone carboxamide inhibitors of endothelial lipase |
| 04/04/2013 | WO2013047601A1 Organic electroluminescence element |
| 04/04/2013 | WO2013046781A1 Intermediate for manufacture of polymerizable compound and process for manufacture thereof |
| 04/04/2013 | WO2012174013A3 Treatment of cardiovascular disease, stroke, and inflammatory conditions |
| 04/04/2013 | US20130085159 Compounds derived from artesunate, preparation process, pharmaceutical composition and use of the respective medicine |
| 04/03/2013 | CN103012502A Heteronuclear iridium gold bicyclo metal compound as well as preparation method and application of compound |
| 04/03/2013 | CN103012397A Pyrazolo quinolinone derivative and preparation method thereof as well as therapeutic application of derivative |
| 04/03/2013 | CN103012370A Method for synthesizing substituted phenylalanine and substituted phenyllactic acid derivatives by using palladium as catalyst |
| 04/03/2013 | CN103012368A Quinoline derivative |
| 04/03/2013 | CN103012367A Quinoline derivative |
| 04/03/2013 | CN103012261A Method for preparing montelukast sodium and intermediate of montelukast sodium |
| 04/03/2013 | CN103012260A Preparation method of pitavastatin calcium intermediate compound |
| 04/03/2013 | CN101808742B Use of metal complex compounds as oxidation catalysts |
| 04/03/2013 | CN101553471B 抗菌喹啉衍生物 Antibacterial quinoline derivatives |
| 04/03/2013 | CN101516834B Isoserine derivatives for use as coagulation factor IXa inhibitors |
| 04/02/2013 | US8410275 Bicyclic derivatives as CETP inhibitors |